Canada’s Calgary Scientific Inc. has become a member of the Health and Life Sciences Technology Alliance Partner (TAP) program of Hitachi Data Systems. As an alliance member, the Calgary, Alberta, imaging software developer will partner with Hitachi on development of Vendor Neutral Archive (VNA) solutions built on the Hitachi Clinical Repository platform...!
Radiologists who held medical directors’ positions with hospitals and health systems collected a median of $32,353 annually, and those who took weekend call earned a median of $2,000 in call compensation, according to a survey¹ conducted and published by the Medical Group Management Association. Medical directors’ compensation, at the low end, was
Community Health Network (CHN), a healthcare system based in east-central Wisconsin, has selected Merge Healthcares iConnect VNA and iConnect Access to provide real-time access to images and patient information across its network.
Lakeland Healthcare Group, a multisite practice including two regional hospitals and affiliated and freestanding clinics in Illinois, will implement Merge Healthcare's suite of cloud-hosted radiology software to improve workflow and achieve meaningful use.
BOSTON Despite recent studies that question the "inappropriate use" of implantable cardioverter-defibrillators (ICDs) in primary prevention, the large OMNI registry, presented May 11 at the 33rd annual scientific sessions of the Heart Rhythm Society (HRS), found that patients who received ICD implants in a non-evidence based manner experienced similar therapeutic benefit and outcomes to those who received evidence-based treatments.
BOSTONIs anti-arrhythmic drug use in ventricular arrhythmia and device patients safe? While the drugs might be useful in some instances, clinicians should not forget about the risks, said Paul Dorian, MD, MSc, during a presentation May 10 at the 33rd annual scientific sessions of the Heart Rhythm Society (HRS).
Boston Scientific has gained CE Mark for its Innova self-expanding bare-metal stent system, which is designed to treat peripheral vascular lesions in arteries above the knee, specifically the superficial femoral artery and proximal popliteal artery.